Author

Georg Tatzreiter

Observed names: G Tatzreiter, G. Tatzreiter

Observed institutions: Seattle Cancer Care Alliance, University of Washington, Donauspital, Fred Hutch Cancer Center, University of California, Irvine Medical Center, Sheffield Teaching Hospitals NHS Foundation Trust, UC Irvine Health, University of Nebraska Medical Center

OpenAlex ID: A5089477351

Routine clinical use of alemtuzumab in patients with heavily pretreated B‐cell chronic lymphocytic leukemia

2006 · Michael Fiegl, Andreas Falkner, et al. · Cancer · 42

Perforating folliculitis, angioedema, hand‐foot syndrome – multiple cutaneous side effects in a patient treated with sorafenib

2009 · Carola Wolber, Astrid Udvardi, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 24

Advances in the Treatment of Relapsed and Refractory Multiple Myeloma in Patients with Renal Insufficiency: Novel Agents, Immunotherapies and Beyond

2021 · Boris Bozic, Jens Rutner, et al. · Cancers · 17

Successful treatment of invasive mould infection affecting lung and brain in an adult suffering from acute leukaemia

2001 · Veronika Buxhofer, Reinhard Ruckser, et al. · European Journal Of Haematology · 9

Perforierende Follikulitis, Angioödem, Hand‐Fuß‐Syndrom – multiple kutane Nebenwirkungen bei einem Patienten unter Sorafenib

2009 · Carola Wolber, Astrid Udvardi, et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 4

A rare case of interstitial pneumonitis after tandem high‐dose melphalan conditioning and autologous stem cell transplantation in multiple myeloma

2004 · Veronika Buxhofer‐Ausch, Reinhard Ruckser, et al. · European Journal Of Haematology · 3

Clin-neuro/medical Oncology

2012 · C.-K. Park, Y.-H. Kim, et al. · Neuro-Oncology · 2

Combination Therapy with Lenalidomide, Bortezomib, Liposomal Doxorubicin and Dexamethasone (LBlipDD) May Overcome Resistance to Prior Treatment with Doxorubicin, Lenalidomide, and Bortezomib in High-Risk Multiple Myeloma (MM).

2007 · Reinhard Ruckser, Georg Tatzreiter, et al. · Blood · 1

Alemtuzumab Is Effective in Patients with Advanced, Pretreated B-Cell Chronic Lymphocytic Leukemia: A Nationwide Study of Routine Use in Austria.

2005 · Michael Fiegl, Andreas Falkner, et al. · Blood · 1

Single center analysis of immunotherapy in mCRC patients.

2012 · Reinhard Ruckser, Selma Hoenigschnabl, et al. · Journal of Clinical Oncology

[High dosage therapy and autologous peripheral stem cell transplantation in breast carcinoma].

2000 · P Kier, R Ruckser, et al. · PubMed

[High dosage chemotherapy with autologous stem cell transplantation in multiple myeloma].

2000 · R Ruckser, P Kier, et al. · PubMed

[High dosage therapy with stem cell transplantation in neuroendocrine carcinoma].

2000 · V Buxhofer, R Ruckser, et al. · PubMed

Results of combined HDR-brachytherapy and external beam therapy in patients with high risk endometrial carcinoma

1997 · G. Tatzreiter, T.H. Knocke, et al. · European Journal of Cancer

282Nephroblastoma: Role of radiotherapy within the frame of the SIOP/GPOH experience

1996 · R. Pötter, M. Flentje, et al. · Radiotherapy and Oncology

628Results of combined HDR-rrachytherapy and external beam therapy in patients with high risk endometrial carcinoma

1996 · G. Tatzreiter, T.H. Knocke, et al. · Radiotherapy and Oncology

383Toxicity following preoperative combined modality therapy in cancers of the oral cavity and oropharynx

1996 · W. Dobrowsky, W. Millesi, et al. · Radiotherapy and Oncology

Works count: 17

Citation count: 103

H-index: 4

I10-index: 3